Norstrud Andrew James 4
4 · Stem Cell Therapy International, Inc. · Filed Feb 16, 2010
Insider Transaction Report
Form 4
Norstrud Andrew James
DirectorChief Financial Officer
Transactions
- Award
Option
2010-01-04$0.11/sh+500,000$55,000→ 1,800,000 totalExercise: $0.11From: 2010-01-04Exp: 2020-01-04→ Common Stock (500,000 underlying)